Stock listing

OTC:TLPPF Telix Pharmaceuticals Limited Stock

US listing (OTC) of Telix Pharmaceuticals Limited · home listing ASX:TLX

Follow Telix Pharmaceuticals Limited into a list and get an email when it puts out news.

Share price · OTC:TLPPF

$8.82 USD -0.33 (-3.6%)

Close on Oct 27, 2026

Day range
$8.75 – $8.82 USDOct 27, 2026
Volume
2,255 sharesOct 27, 2026
Telix Pharmaceuticals Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:TLX · Home$13.08 AUD-0.055 (-0.4%)184,190$13.02$13.20$13.00$13.13Delayed 15+ min · 10:57 AM GMT+11, Nov 2, 2026
NASDAQ:TLX$9.03 USD-0.12 (-1.3%)223,697$8.94$9.06$8.91$9.15Close on Oct 27, 2026
OTC:TLPPF$8.82 USD-0.331 (-3.6%)2,255$8.75$8.82$8.75$9.15Close on Oct 27, 2026
Frankfurt:T3X€8.158 EUR+0.227 (+2.9%)—€8.181€8.181€8.132€7.931Close on Oct 30, 2026
Ticker
OTC:TLPPF
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call

    Thu, Aug 20, 2026 · 7:00 PM ET

    Watch Transcript

  • Telix Pharmaceuticals (ASX:TLX) Q4 2025 Earnings Call

    Thu, Aug 21, 2025 · 7:30 PM ET

    Watch Transcript

Latest news

Notice of General Meeting

Oct 29, 2026

Telix Reports Third Quarter 2026 Financial Performance

Oct 20, 2026

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

Oct 14, 2026

Telix to Host Capital Markets Day in Melbourne on November 4, 2026

Oct 9, 2026

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara (floretyrosine F 18)

Oct 6, 2026

Notification of cessation of securities - TLX

Oct 4, 2026

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

Sep 29, 2026

FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging

Sep 29, 2026

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

Sep 20, 2026

Telix and ITM Join Forces to Create Radiopharma Powerhouse

Sep 20, 2026

All Telix Pharmaceuticals Limited news

Financings

  • At-the-market programme of new fully paid ordinary shares in the form of American Depository Shares (ADSs)

    Aug 20, 2026

    Announced: Morgan Stanley & Co. LLC +1

    Dealers: Morgan Stanley & Co. LLC, William Blair & Company, L.L.C.

    Use of proceeds: To facilitate greater access to the Company's securities on the Nasdaq stock exchange

    Announced Aug 20, 2026

Read by 6ix AI from the company's releases

Decks

Telix Pharmaceuticals Limited on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
84 in the last 12 months · 382 in all · newest Oct 29, 2026 · oldest 2017
Calls
2 calls with a replay · 2 with a transcript · latest Aug 20, 2026
Decks
56 decks · latest Sep 22, 2026

Where Telix Pharmaceuticals Limited is listed

ListingExchangeCountryCurrency
ASX:TLX · Home listingASXAustraliaAUD
NASDAQ:TLXNASDAQUnited StatesUSD
LS Exchange:A2H7JKLS ExchangeGermanyEUR
gettex:T3XgettexGermanyEUR
Tradegate:T3XTradegateGermanyEUR
OTC:TLPPF · This pageOTCUnited StatesUSD
BOATS:TLXBOATSUnited StatesUSD
Lang & Schwarz:A2H7JKLang & SchwarzGermanyEUR
Frankfurt:T3XFrankfurtGermanyEUR
BMV:TLX1NBMVMexicoMXN
Dusseldorf:T3XDusseldorfGermanyEUR
BIVA:TLX1NBIVAMexicoMXN
Frankfurt:T3X0FrankfurtGermanyEUR
Hamburg:T3XHamburgGermanyEUR
Munich:T3XMunichGermanyEUR
Stuttgart:T3XStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Telix Pharmaceuticals Limited.